Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab(®)

INTRODUCTION: Since epithelial growth factor receptor (EGFR) overexpression is linked to a variety of malignancies, it is an attractive target for immune therapy including chimeric antigen receptor (CAR)-engineered T cells. Unfortunately, CAR T cell therapy harbors the risk of severe, even life-thre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jureczek, Justyna, Feldmann, Anja, Bergmann, Ralf, Arndt, Claudia, Berndt, Nicole, Koristka, Stefanie, Loureiro, Liliana Rodrigues, Mitwasi, Nicola, Hoffmann, Anja, Kegler, Alexandra, Bartsch, Tabea, Bachmann, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297505/
https://www.ncbi.nlm.nih.gov/pubmed/32606767
http://dx.doi.org/10.2147/OTT.S245169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297505/
https://www.ncbi.nlm.nih.gov/pubmed/32606767
http://dx.doi.org/10.2147/OTT.S245169

Ejemplares similares